Literature DB >> 3566706

Cellular localization and substrate specificity of isoelectric forms of human liver neuraminidase activity.

J Spaltro, J A Alhadeff.   

Abstract

The four major isoelectric forms of human liver neuraminidase (with pI values between 3.4 and 4.8) have been isolated by preparative isoelectric focusing and characterized with regard to their substrate specificity using glycoprotein, glycopeptide, oligosaccharide and ganglioside natural substrates. All forms exhibited a rather broad linkage specificity and were capable of hydrolyzing sialic acid glycosidically linked alpha 2-3, alpha 2-6 and alpha 2-8, although differential rates of hydrolysis of the substrates were found for each form. The most acidic form 1 (pI 3.4) was most active on sialyl-lactose, whereas form 2 (pI 3.9) and 3 (pI 4.4) were most active on the more hydrophobic ganglioside substrates. Form 4 (pI 4.8) was most active on the low-Mr hydrophilic substrates (fetuin glycopeptide, sialyl-lactose). Each form was less active on the glycoprotein fetuin than on a glycopeptide derived from fetuin. Organelle-enriched fractions were prepared from fresh human liver tissue and neuraminidase activity on 2'-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid was recovered in plasma membrane, microsomal, lysosomal and cytosolic preparations. Isoelectric focusing of the neuraminidase activity recovered in each of these preparations resulted in significantly different isoelectric profiles (number, relative amounts and pI values of forms) for each preparation. The differential substrate specificity of the isoelectric forms and the different isoelectric focusing profiles of neuraminidase activity recovered in subcellular-enriched fractions suggest that specific isoelectric forms with broad but defined substrate specificity are enriched at separate sites within the cell.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3566706      PMCID: PMC1147535          DOI: 10.1042/bj2410137

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  FLUOROMETRIC ASSAY OF SIALIC ACID IN BRAIN GANGLIOSIDES.

Authors:  H HESS; E ROLDE
Journal:  J Biol Chem       Date:  1964-10       Impact factor: 5.157

2.  Studies on fetuin, a glycoprotein of fetal serum. II. Nature of the carbohydrate units.

Authors:  R G SPIRO
Journal:  J Biol Chem       Date:  1962-02       Impact factor: 5.157

3.  Purification of amine oxidase from beef plasma.

Authors:  C W TABOR; H TABOR; S M ROSENTHAL
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

4.  Analysis of neuraminidase isozyme phenotypes in mammalian tissues: an electrophoretic approach.

Authors:  P B Samollow; J L VandeBerg; H W Kunz; T J Gill
Journal:  Biochem Biophys Res Commun       Date:  1985-02-15       Impact factor: 3.575

5.  Solubilization, stabilization and isoelectric focusing of human liver neuraminidase activity.

Authors:  J Spaltro; J A Alhadeff
Journal:  Biochim Biophys Acta       Date:  1984-07-30

6.  The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation.

Authors:  K Suzuki
Journal:  J Neurochem       Date:  1965-07       Impact factor: 5.372

7.  Automated assay of lactate dehydrogenase in urine.

Authors:  N J Hochella; S Weinhouse
Journal:  Anal Biochem       Date:  1965-11       Impact factor: 3.365

8.  Isolation and characterization of an oligosaccharide- and glycoprotein-specific sialidase from human leucocytes.

Authors:  R Schauer; M Wember; H Tschesche
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1984-04

9.  Characterization, purification, and subcellular localization of bovine thyroid sialidases.

Authors:  G Van Dessel; M De Wolf; A Lagrou; H Hilderson; W Dierick
Journal:  J Biochem       Date:  1984-10       Impact factor: 3.387

10.  Methylumbelliferyl-N-acetylneuraminic acid sialidase in human liver.

Authors:  W R den Tandt; S Scharpe
Journal:  Biochem Med       Date:  1984-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.